Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BioSig Technologies, Inc.

Get SEC filing alerts via email and in your feed for BioSig Technologies, Inc.

BSGM

BioSig Technologies, Inc.

About BioSig Technologies, Inc.

BioSig Technologies, Inc. develops advanced medical device technology focused on electrophysiology (EP) with its PURE EP™ Platform, which enhances real-time cardiac signal acquisition and analysis during catheter ablation of complex arrhythmias like atrial fibrillation and ventricular tachycardia. Serving electrophysiologists and EP labs, BioSig’s platform improves signal clarity and procedural precision, aiming to optimize ablation outcomes through proprietary hardware and software integrated into existing clinical workflows.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from BioSig Technologies, Inc.

1
1
BioSig Technologies, Inc. Streamex Corp. Reports No Revenue and $46.7 Million Net Loss in Latest Quarterly Filing

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
BioSig Technologies, Inc. Streamex Corp. Reports No Revenue and $462.8 Million Net Loss in 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
BioSig Technologies, Inc. Streamex Corp. Reports No Revenue and Increased Losses in Latest Financial Filing

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
BioSig Technologies, Inc. BioSig Technologies Reports No Revenue and $20.4 Million Net Loss in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
BioSig Technologies, Inc. BioSig Technologies Reports No Revenue and Improved Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BioSig Technologies, Inc. BioSig Technologies Reports $10.3 Million Net Loss for 2024, Revenue Increases to $40,000

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
BioSig Technologies, Inc. BioSig Technologies Reports Improved Financials, Reduced Losses, and Strategic Restructuring

Via official filing (AI summary) | over 1 year ago | 0 comments